182 related articles for article (PubMed ID: 37151069)
1. Quantitative Proteomics Combined with Network Pharmacology Analysis Unveils the Biological Basis of Schisandrin B in Treating Diabetic Nephropathy.
Song J; Zhang B; Zhang H; Cheng W; Liu P; Kang J
Comb Chem High Throughput Screen; 2024; 27(2):284-297. PubMed ID: 37151069
[TBL] [Abstract][Full Text] [Related]
2. Schisandrin B alleviates diabetic nephropathy through suppressing excessive inflammation and oxidative stress.
Mou Z; Feng Z; Xu Z; Zhuang F; Zheng X; Li X; Qian J; Liang G
Biochem Biophys Res Commun; 2019 Jan; 508(1):243-249. PubMed ID: 30477745
[TBL] [Abstract][Full Text] [Related]
3. Transcriptomic analyses reveal the molecular mechanisms of schisandrin B alleviates CCl
Zhang H; Chen Q; Dahan A; Xue J; Wei L; Tan W; Zhang G
Chem Biol Interact; 2019 Aug; 309():108675. PubMed ID: 31150632
[TBL] [Abstract][Full Text] [Related]
4. Huangkui capsule attenuates renal fibrosis in diabetic nephropathy rats through regulating oxidative stress and p38MAPK/Akt pathways, compared to α-lipoic acid.
Mao ZM; Shen SM; Wan YG; Sun W; Chen HL; Huang MM; Yang JJ; Wu W; Tang HT; Tang RM
J Ethnopharmacol; 2015 Sep; 173():256-65. PubMed ID: 26226437
[TBL] [Abstract][Full Text] [Related]
5. Nepeta angustifolia C. Y. Wu improves renal injury in HFD/STZ-induced diabetic nephropathy and inhibits oxidative stress-induced apoptosis of mesangial cells.
Huang S; Tan M; Guo F; Dong L; Liu Z; Yuan R; Dongzhi Z; Lee DS; Wang Y; Li B
J Ethnopharmacol; 2020 Jun; 255():112771. PubMed ID: 32201300
[TBL] [Abstract][Full Text] [Related]
6. Network pharmacology analysis combined with experimental validation to explore the therapeutic mechanism of Schisandra Chinensis Mixture on diabetic nephropathy.
Ma Y; Deng Y; Li N; Dong A; Li H; Chen S; Zhang S; Zhang M
J Ethnopharmacol; 2023 Feb; 302(Pt A):115768. PubMed ID: 36280016
[TBL] [Abstract][Full Text] [Related]
7. Schisandrin B attenuates CCl
Chen Q; Zhang H; Cao Y; Li Y; Sun S; Zhang J; Zhang G
Drug Des Devel Ther; 2017; 11():2179-2191. PubMed ID: 28794616
[TBL] [Abstract][Full Text] [Related]
8. Integrated Network Pharmacology Analysis and Experimental Validation to Elucidate the Mechanism of Acteoside in Treating Diabetic Kidney Disease.
Zhang SJ; Zhang YF; Bai XH; Zhou MQ; Zhang ZY; Zhang SX; Cao ZJ; Wang L; Ding SW; Zheng HJ; Liu YN; Yu GY; Liu WJ
Drug Des Devel Ther; 2024; 18():1439-1457. PubMed ID: 38707616
[TBL] [Abstract][Full Text] [Related]
9. Structural determinants of schisandrin B which enhance mitochondrial functional ability and glutathione status as well as heat shock protein expression in rat hearts and H9c2 cells.
Ko KM; Chiu PY
Mol Cell Biochem; 2005 Aug; 276(1-2):227-34. PubMed ID: 16132705
[TBL] [Abstract][Full Text] [Related]
10. Influence of LncRNA UCA1 on glucose metabolism in rats with diabetic nephropathy through PI3K-Akt signaling pathway.
Shi CH; Huang Y; Li WQ; Chen RG
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):10058-10064. PubMed ID: 31799676
[TBL] [Abstract][Full Text] [Related]
11. Astragalus Polysaccharide Ameliorates Renal Inflammatory Responses in a Diabetic Nephropathy by Suppressing the TLR4/NF-κB Pathway.
Guo M; Gao J; Jiang L; Dai Y
Drug Des Devel Ther; 2023; 17():2107-2118. PubMed ID: 37489175
[TBL] [Abstract][Full Text] [Related]
12.
Chen Y; Zheng YF; Lin XH; Zhang JP; Lin F; Shi H
Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34165163
[No Abstract] [Full Text] [Related]
13. Schisandrol A, the main active ingredient of Schisandrae Chinensis Fructus, inhibits pulmonary fibrosis through suppression of the TGF-β signaling pathway as revealed by UPLC-Q-TOF/MS, network pharmacology and experimental verification.
Wu Z; Jia M; Zhao W; Huang X; Yang X; Chen D; Qiaolongbatu X; Li X; Wu J; Qian F; Lou Y; Fan G
J Ethnopharmacol; 2022 May; 289():115031. PubMed ID: 35091014
[TBL] [Abstract][Full Text] [Related]
14. Effects and clinical significance of pentoxifylline on the oxidative stress of rats with diabetic nephropathy.
An ZM; Dong XG; Guo Y; Zhou JL; Qin T
J Huazhong Univ Sci Technolog Med Sci; 2015 Jun; 35(3):356-361. PubMed ID: 26072073
[TBL] [Abstract][Full Text] [Related]
15. Ursolic acid improves diabetic nephropathy via suppression of oxidative stress and inflammation in streptozotocin-induced rats.
Xu HL; Wang XT; Cheng Y; Zhao JG; Zhou YJ; Yang JJ; Qi MY
Biomed Pharmacother; 2018 Sep; 105():915-921. PubMed ID: 30021385
[TBL] [Abstract][Full Text] [Related]
16. Effect of miR-1297 on Kidney Injury in Rats with Diabetic Nephropathy through the PTEN/PI3K/AKT Pathway.
Chen N; Liu H; Jiang X; Tang N; Fan W; Ji W; Zhou Z
Arch Esp Urol; 2024 Mar; 77(2):183-192. PubMed ID: 38583011
[TBL] [Abstract][Full Text] [Related]
17. Integrating network pharmacology and experimental validation to decipher the mechanism of the Chinese herbal prescription modified Shen-Yan-Fang-Shuai formula in treating diabetic nephropathy.
Yu B; Zhou M; Dong Z; Zheng H; Zhao Y; Zhou J; Zhang C; Wei F; Yu G; Liu WJ; Liu H; Wang Y
Pharm Biol; 2023 Dec; 61(1):1222-1233. PubMed ID: 37565668
[TBL] [Abstract][Full Text] [Related]
18. Liraglutide attenuates renal tubular ectopic lipid deposition in rats with diabetic nephropathy by inhibiting lipid synthesis and promoting lipolysis.
Su K; Yi B; Yao BQ; Xia T; Yang YF; Zhang ZH; Chen C
Pharmacol Res; 2020 Jun; 156():104778. PubMed ID: 32247822
[TBL] [Abstract][Full Text] [Related]
19. Alterations in susceptibility to carbon tetrachloride toxicity and hepatic antioxidant/detoxification system in streptozotocin-induced short-term diabetic rats: effects of insulin and Schisandrin B treatment.
Mak DH; Ko KM
Mol Cell Biochem; 1997 Oct; 175(1-2):225-32. PubMed ID: 9350055
[TBL] [Abstract][Full Text] [Related]
20. Secoisolariciresinol diglucoside in high-fat diet and streptozotocin-induced diabetic nephropathy in rats: a possible renoprotective effect.
Sherif IO
J Physiol Biochem; 2014 Dec; 70(4):961-9. PubMed ID: 25316298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
